Literature DB >> 1688876

Quantitative analysis of endoneurial T-cells in human sural nerve biopsies.

D R Cornblath1, D E Griffin, D Welch, J W Griffin, J C McArthur.   

Abstract

We used immunocytochemical methods on sural nerve biopsies from 42 patients with peripheral neuropathy to identify mononuclear cells, determine whether lymphocytic infiltration occurs in a variety of neuropathies, and identify the subtypes of lymphocytes. Immunostained cells were present in 76% of nerve biopsies. CD3+ cells (T lymphocytes) were greatest in density (cells/mm2). In patients whose CD4:CD8 T cell ratio was measured also in blood and cerebrospinal fluid, the CD4:CD8 T cell ratio was similar in all three compartments. These findings suggest that T lymphocytes are frequently present in nerves obtained from patients with various types of neuropathies and raise questions about factors that attract T lymphocytes into nerve that may be important in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688876     DOI: 10.1016/0165-5728(90)90082-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

1.  IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration.

Authors:  Collin-Jamal Smith; Denise E Allard; Yan Wang; James F Howard; Stephanie A Montgomery; Maureen A Su
Journal:  J Immunol       Date:  2018-01-24       Impact factor: 5.422

Review 2.  Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies.

Authors:  Jolien Wolbert; Mandy I Cheng; Gerd Meyer zu Horste; Maureen A Su
Journal:  JCI Insight       Date:  2020-02-13

3.  Defective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathy.

Authors:  Maureen A Su; Dan Davini; Philip Cheng; Karen Giang; Una Fan; Jason J DeVoss; Kellsey P A Johannes; Lorelei Taylor; Anthony K Shum; Mariella Valenzise; Antonella Meloni; Helene Bour-Jordan; Mark S Anderson
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

4.  Progressive polyradiculoneuropathy in diabetes: correlation of variables and clinical outcome after immunotherapy.

Authors:  S S Jaradeh; T E Prieto; L J Lobeck
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-11       Impact factor: 10.154

5.  Circulating cytotoxic immune components in dominant Charcot-Marie-Tooth syndrome.

Authors:  L L Williams; B T Shannon; F S Wright
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

6.  Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies.

Authors:  Gerd Meyer Zu Horste; Holger Heidenreich; Helmar C Lehmann; Soldano Ferrone; Hans-Peter Hartung; Heinz Wiendl; Bernd C Kieseier
Journal:  Glia       Date:  2010-01-01       Impact factor: 7.452

7.  Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment.

Authors:  Denise E Allard; Yan Wang; Jian Joel Li; Bridget Conley; Erin W Xu; David Sailer; Caellaigh Kimpston; Rebecca Notini; Collin-Jamal Smith; Emel Koseoglu; Joshua Starmer; Xiaopei L Zeng; James F Howard; Ahmet Hoke; Steven S Scherer; Maureen A Su
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808

Review 8.  Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.

Authors:  Emily K Mathey; Susanna B Park; Richard A C Hughes; John D Pollard; Patricia J Armati; Michael H Barnett; Bruce V Taylor; P James B Dyck; Matthew C Kiernan; Cindy S-Y Lin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-12       Impact factor: 10.154

Review 9.  Can antiglycolipid antibodies present in HIV-infected individuals induce immune demyelination?

Authors:  S Petratos; M E Gonzales
Journal:  Neuropathology       Date:  2000-12       Impact factor: 1.906

10.  Characterization of diabetic neuropathy progression in a mouse model of type 2 diabetes mellitus.

Authors:  Cristian De Gregorio; David Contador; Mario Campero; Marcelo Ezquer; Fernando Ezquer
Journal:  Biol Open       Date:  2018-09-05       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.